Molecular mechanisms of neuroendocrine differentiation in prostate cancer progression

BACKGROUND: Rapid evolution of the therapeutic management of prostate cancer, especially in in second-generation androgen inhibitors, has increased the opportunity of transformation from prostate cancer (PCa) to neuroendocrine prostate cancer (NEPC). NEPC still lacks effective diagnostic and therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yuchen, Ning, Songyi, Hu, Jianpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189092/
https://www.ncbi.nlm.nih.gov/pubmed/35633416
http://dx.doi.org/10.1007/s00432-022-04061-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189092/
https://www.ncbi.nlm.nih.gov/pubmed/35633416
http://dx.doi.org/10.1007/s00432-022-04061-7

Ejemplares similares